Literature DB >> 1607151

Nasopharyngeal and nasal malignant lymphoma: a clinicopathological study of 54 cases.

Y L Ye1, M H Zhou, X Y Lu, Y R Dai, W X Wu.   

Abstract

Forty-one cases of nasopharyngeal and 13 cases of nasal malignant lymphoma have been examined histologically and immunohistochemically. All of the cases were non-Hodgkin's lymphoma; one case was of follicular type and the remaining 53 were of diffuse type. Large cell lymphoma comprised 48% of cases and most of the immunoblastic lymphomas showing pleomorphism occurred in the nose. Twenty-seven cases were of T-cell and 21 of B-cell phenotype. The predominance of T-cell lymphoma was due to an increased incidence of these in the nose, the T:B ratio of 3.33:1 contrasting with a 1:1.05 ratio in the nasopharynx. Nasopharyngeal lymphomas seem to show an intermediate incidence between the T-cell predominance in the nose and a B-cell predominance in the oropharynx. Since the large cell type of lymphoma was predominant, the differential diagnosis from undifferentiated carcinoma is important and is facilitated by the use of immunostaining methods.

Entities:  

Mesh:

Year:  1992        PMID: 1607151     DOI: 10.1111/j.1365-2559.1992.tb01036.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  3 in total

1.  Epstein-Barr virus infection in sinonasal non-Hodgkin's lymphomas.

Authors:  P Luzi; L Leoncini; I Funtò; A Bruni; S Lazzi; L Pacenti; P Tosi
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

2.  Primary extranodal non-hodgkin lymphoma of the head and neck in patients with acquired immunodeficiency syndrome: a clinicopathologic study of 24 patients in a single hospital of infectious diseases in Argentina.

Authors:  Marcelo Corti; María Villafañe; Alicia Bistmans; Marina Narbaitz; Leonardo Gilardi
Journal:  Int Arch Otorhinolaryngol       Date:  2014-04-09

3.  Nasopharyngeal Lymphoma: A 22-Year Review of 35 Cases.

Authors:  Chien-Yu Hsueh; Ching-Fen Yang; Jyh-Pyng Gau; Edward C Kuan; Ching-Yin Ho; Tzeon-Jye Chiou; Liang-Tsai Hsiao; Ting-An Lin; Ming-Ying Lan
Journal:  J Clin Med       Date:  2019-10-03       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.